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Ca2/calmodulin-dependent protein kinase kinase 
(CaMKK) is a serine/threonine-directed kinase that is acti-
vated following increases in intracellular Ca2. CaMKK acti-
vates Ca2/calmodulin-dependent protein kinase I, Ca2/cal-
modulin-dependent protein kinase IV, and theAMP-dependent
protein kinase in a number of physiological pathways, including
learning and memory formation, neuronal differentiation, and
regulation of energy balance. Here, we report the novel regula-
tion of CaMKK activity by multisite phosphorylation. We
identify three phosphorylation sites in the N terminus of
CaMKK, which regulate its Ca2/calmodulin-independent
autonomous activity. We then identify the kinases responsible
for these phosphorylations as cyclin-dependent kinase 5
(CDK5) and glycogen synthase kinase 3 (GSK3). In addition to
regulation of autonomous activity, we find that phosphorylation
of CaMKK regulates its half-life.We find that cellular levels of
CaMKK correlate with CDK5 activity and are regulated devel-
opmentally in neurons. Finally, we demonstrate that appropri-
ate phosphorylation of CaMKK is critical for its role in neurite
development. These results reveal a novel regulatory mecha-
nism for CaMKK-dependent signaling cascades.
The Ca2/calmodulin-dependent protein kinase kinases
(CaMKKs)2 are serine/threonine-directed protein kinases that
are activated following increases in intracellular Ca2 concen-
tration. There are two CaMKK isoforms, CaMKK and
CaMKK, that are encoded by two separate genes. The
CaMKKs have similar domain structures consisting of N- and
C-terminal domains of unknown function, a kinase domain,
and an autoregulatory domain comprising overlapping autoin-
hibitory and calmodulin (CaM) binding regions (1). Binding of
Ca2/CaM to the CaM binding domain releases autoinhibition
allowing for maximal catalytic activity. Human CaMKK and
CaMKK share 65% protein sequence homology, with the
highest degree of similarity in their kinase domains, and the
biggest differences in the N- and C-terminal domains (2).
The CaMKKs are well characterized activators of the Ca2/
calmodulin-dependent protein kinases I (CaMKI) and IV
(CaMKIV) (2–4). In this context, the CaMKKs are upstream
activators of Ca2/CaM-dependent signaling cascades. These
cascades are activated following an elevation in intracellular
Ca2, which leads to Ca2 binding to CaM. Upon Ca2 bind-
ing, CaM assumes an active conformation that allows it to bind
target proteins, including the CaMKKs and the CaMKs (5).
Binding of Ca2/CaM to the CaMKs allows the activation loop
of the kinase to assume a conformation in which it can then be
phosphorylated by the CaMKKs (6, 7). Thus, CaMKK/CaMK
signaling cascades are regulated at multiple levels by
Ca2/CaM.
CaMKK and CaMKK are expressed most abundantly in
the brain (2), where CaMKK/CaMK signaling cascades play
important roles in a number of physiologically important neu-
ronal processes, including learning and memory (8, 9), neuro-
nal differentiation and migration (10), neurite outgrowth (11–
13), and synaptogenesis (14). In addition, CaMKK, but not
CaMKK, is an upstream activator of theAMP-dependent pro-
tein kinase (AMPK) (15–17). The regulation of AMPK by
CaMKK is important for regulating energy balance in the
hypothalamus (18).
Although both CaMKKs activate CaMKI and CaMKIV sim-
ilarly, there are important differences in how the two are regu-
lated. First, CaMKK can be phosphorylated by protein kinase
A (PKA) leading to the recruitment of 14-3-3 and inactivation
of the enzyme (19, 20). Although some PKA sites are conserved
in both CaMKKs, the regulation of CaMKK by PKA has not
been reported. In addition, although CaMKK activity is
almost exclusively dependent on Ca2/CaM for activity,
CaMKK has considerable autonomous activity in the absence
of Ca2/CaM binding (2, 21). Despite high autonomous activ-
ity, CaMKK pathways involving substrates that are not them-
selves Ca2/CaM-regulated, such as AMPK, still require a
Ca2/CaM signal for activation (17). In addition, CaMKK
purified from bacterial andmammalian sources display varying
amounts of autonomous activity (15, 21). These observations
led us to believe that there are additional Ca2/CaM-indepen-
dent methods of CaMKK regulation.
In this study, we describe the regulation of CaMKK by
phosphorylation and identify cyclin-dependent kinase 5
(CDK5) and glycogen synthase kinase 3 (GSK3) as putative
upstream kinases. Phosphorylation of CaMKK in vitro
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decreases the Ca2/CaM-independent, autonomous activity of
the enzyme. In addition, we find that CDK5/GSK3 phosphory-
lation regulates the turnover of CaMKK in vivo. Finally, we
demonstrate that appropriate phosphorylation of CaMKK is
critical for its function in neurite development in primary neu-
ronal cultures.
EXPERIMENTAL PROCEDURES
Purification of CaMKK—Full-length rat CaMKK was
expressed as a GST fusion protein in BL21(DE3) Escherichia
coli (Stratagene, 200131) from the pGEX-KG-PreS-CaMKK
vector and purified by glutathione and calmodulin-Sepharose
chromatography using a procedure described previously (21).
The final purification step involved proteolytic removal of the
GST tag. For purification frommammalian cells, full-length rat
FLAG-CaMKK was expressed from the pSG5 vector tran-
siently overexpressed in HEK 293a cells using Lipofectamine
2000 (Invitrogen, 11668-019). For each transfection, 20 g of
DNA and 40 l of Lipofectamine 2000 were used per 15-cm
dish following the manufacturer’s suggested protocol. HEK
293a cells were about 75% confluent at the time of transfection,
and cultures were maintained in DMEM (Mediatech, 10-013-
CV) with 10% FBS (Gemini Bio-Products, 900-108). Lysates
were made from cells 24–36 h after transfection using 1
ml/plate of Nonidet P-40 lysis buffer (25 mM Tris-HCl, pH 7.5,
50 mM NaCl, 0.5% Nonidet P-40, 25 mM NaH2PO4, 2 mM
EGTA, 2 mM EDTA, 40 mM NaF, 10 g/ml leupeptin, 100
g/ml Pefabloc, and 100 nM okadaic acid). Lysate was clarified
by centrifugation at 18,000  g for 30 min. Supernatant was
then incubated for 2 h with constant rocking at 4 °C with 20 l
of anti-FLAGM2-agarose (Sigma, A2220) per ml of lysate. The
resin was washed twice with lysis buffer and once with TBS
prior to elution for 1 h on ice with 40 l of TBS containing 300
ng/l FLAG peptide (Sigma, F3290). For -phosphatase-
treated CaMKK, purification was performed as above up to
the washes in lysis buffer. At this point, the resin was washed
twice with 1 -phosphatase reaction buffer (New England
Biolabs, P0753) before being resuspended in 50 l of -phos-
phatase reaction buffer plus 2.0 l of -phosphatase (New Eng-
landBiolabs, P0753) perml of starting lysate. Phosphatase reac-
tion was incubated at 30 °C for 30 min before being washed
three times with lysis buffer, once with TBS, and eluted as
above. Protein concentrations were measured by fractionating
aliquots of each preparation on a 10% SDS-polyacrylamide gel
along with BSA standards followed by quantification of Coo-
massie Blue-stained bands.
Full-length human FLAG-CaMKK for mass spectrometry
analysis (wild type and individual S129A, S133A, and S137A
mutants) was cloned into pcDNA3 and transiently expressed in
COS-7 cells. After 28 h, cells were harvested in lysis buffer (50
mMTris-HCl, pH 7.4, 150mMNaCl, 1.0% Triton X-100, 50 mM
NaF, 5 mM pyrophosphate, 1 mM EDTA, 1 mM EGTA, and pro-
tease inhibitor mixture (Roche Applied Science)) and clarified
by centrifugation. Lysates were incubated with 20 l per 10-cm
dish of anti-FLAGM2-agarose overnight at 4 °C with constant
rotation. Lysates were washed extensively with PBS. Where
required, FLAG-CaMKKwas eluted in 50-l fractions using 1
mg/ml FLAG peptide in PBS.
Site-directedMutagenesis—Allmutants used were generated
using the QuikChange II XL site-directed mutagenesis kit
(Stratagene, 200521). Primers were site-specific and are listed
in supplemental Table 1. Mutations were confirmed by
sequencing the entire coding region of mutated constructs at
the Duke University DNA Analysis Facility.
CaMKK Kinase Assays—CaMKK catalytic activity was
assessed by its ability to phosphorylate a bacterially expressed,
catalytically inactive AMPK1D139A11 heterotrimer. The cat-
alytic aspartic acid (Asp-139)wasmutated in theAMPK1 sub-
unit to eliminate background caused by autophosphorylation.
Purification of AMPK111 from bacteria has been described
previously (22). For each 25-l assay, 50 ng of partially puri-
fied CaMKK was incubated in a buffer containing 1.5 M
AMPK1D139A11, 0.1% Tween 20, 50 mM HEPES, pH 7.0, 150
mM NaCl, 6.25 mM MgCl2, 0.5 mM DTT, 200 M ATP, and 2
Ci of EasyTides [-32P]ATP (PerkinElmer Life Sciences).
Assays measuring Ca2/CaM autonomous activity also con-
tained 1 mM EGTA, and assays measuring Ca2/CaM-depen-
dent activity contained 1 mM CaCl2 and 1 M bovine testis
CaM. Reactions were terminated at the times indicated in the
figure legends by the addition of SDS-loading buffer followed
by boiling of the samples. The samples were resolved on 10%
SDS-polyacrylamide gels and stained with Coomassie Blue.
Gels were dried and subjected to autoradiography. Bands cor-
responding to the -subunit of AMPK were cut from the gel,
and the amount of 32P incorporated was measured using scin-
tillation counting.
CaMKK Phosphopeptide Sequencing—FLAG-CaMKK
(100 ng) was heated for 5 min at 100 °C, then reduced and alky-
lated with iodoacetamide, and digested in solution with trypsin
(Promega) overnight at 37 °C. In solution, digestion was
required for identification of the 121–139 and 121–142 pep-
tides. Digests were acidified with formic acid and analyzed by
LC-MS/MS. Chromatography was performed on a PepMap300
C18 column running at 500 nl/min with buffer A, 0.1% formic
acid, and buffer B, 80% acetonitrile, 0.1% formic acid, using a
Dionex 3000 rapid separation liquid chromatography-nano liq-
uid chromatography. Peptides were resolved with a 40-min
4–60% B solvent gradient. Mass spectrometry was performed
on a 5600 TripleTOFMS (AB-Sciex) using anMS/MS program
that specifically targeted CaMKK(121–139) and -(121–142)
peptides as well as a standard information-dependent acquisi-
tion MS/MS method.
CaMKK TOF Analysis—FLAG-CaMKK was eluted from
anti-FLAGM2-agarose beads by washing with 100mM glycine,
pH 2.7, precipitated with methanol, and resuspended in 30%
acetic acid before injection onto the liquid chromatography-
MS. Chromatography was performed on a Dionex 3000 liquid
chromatography using a 2.1  100-mm 300SB-C8 column
(Agilent) at a flow rate of 250 l/min. Buffer A is 0.1% formic
acid; Buffer B is acetonitrile, 0.1% formic acid. Proteins were
resolved on a 3–55% B gradient over 30 min. Mass spectrome-
try was performed on a QSTAR Pulsar i Q-TOF (Applied Bio-
systems) using a TurboIonSpray source (Applied Biosystems).
Source conditions were as follows: gas  16 p.s.i., gas temper-
ature  120 °C, and source voltage  5000 V.
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Phosphorylation of CaMKK by p35/CDK5 and GSK3—
GST-CaMKK was purified from E. coli through the glutathi-
one-Sepharose step (21). Five g of GST-CaMKK D311A or
GST-CaMKK D311A, S137A were then incubated with 0.234
g of active CDK5/p35 (Millipore, 14-477) in a 25-l reaction
containing 0.1% Tween 20, 50 mM HEPES, pH 7.0, 150 mM
NaCl, 6.25 mMMgCl2, 0.5 mMDTT, 200 MATP, and 5 Ci of
EasyTides [-32P]ATP (PerkinElmer Life Sciences). Reactions
were terminated at the indicated times by adding SDS-PAGE
loading dye and boiling. The samples were resolved on 10%
SDS-polyacrylamide gels and stained with Coomassie Blue.
Gels were dried and subjected to autoradiography.
To examine the requirement for CDK5/p35 priming of
CaMKK, 0.5 g of phosphatase-treated FLAG-CaMKK
purified fromHEK293a cells was preincubatedwith 0.234g of
active CDK5/p35 (Millipore, 14-477) in a 25-l reaction con-
taining 0.1% Tween 20, 50 mM HEPES, pH 7.0, 150 mM NaCl,
6.25 mM MgCl2, 0.5 mM DTT, and 200 M ATP for an hour.
Samples were then treated with 1 M roscovitine (Santa Cruz
Biotechnology, sc-24002) to inhibit CDK5 before addition of
0.234 g of active GSK-3 (Millipore, 14-538). Reactions were
terminated at the indicated times by addition of SDS-PAGE
loading dye and boiling. Sampleswere then fractionated on 10%
SDS-polyacrylamide gels and immunoblotted with the indi-
cated antibodies.
Immunoblotting—Extracts were resolved on 8 or 10% SDS-
polyacrylamide gels and transferred to Immobilon-FL PVDF
membranes (Millipore, IPFL00010). Membranes were blocked
in a buffer containing 0.2 PBS, 0.1% casein, 0.5% fish gelatin,
and 0.04% sodium azide for 1 h at room temperature. Primary
antibodies were diluted in blocking buffer with 0.1% Tween 20
at the following concentrations: panCaMKK (BD Biosciences,
610545) 1:1000; phosphoserine (BD Biosciences, 612546)
1:1000; FLAG (Sigma, F1804) 1:1000; FLAG (Santa Cruz Bio-
technology, sc-807) 1:500; CaMKI 1:1000; CDK5 (Santa Cruz
Biotechnology, sc-173) 1:500; p35 (Santa Cruz Biotechnology,
sc-820) 1:500;-actin (Sigma, A5441) 1:10,000; and pan-14-3-3
(Abcam, ab14112) 1:1000. After incubation with primary anti-
body, membranes were washed with 1 PBS containing 0.1%
Tween 20. Membranes were then incubated with appropri-
ate fluorescently conjugated secondary antibodies, either
IRDye800 goat anti-mouse IgG (Rockland, 610-132–121) or
Alexa Fluor 680 goat anti-rabbit IgG (Molecular Probes,
A21109), at a 1:5000 dilution in blocking buffer containing 0.1%
Tween 20 and 0.02% SDS. Membranes were washed with 1
PBS containing 0.1%Tween 20.Membranes were then scanned
with an Odyssey Infrared Imager (Li-Cor Biosciences), and
quantification of bands was performed with the Odyssey soft-
ware version 3.0.
Two-dimensional Gel Electrophoresis—Isoelectric focusing
step was performed in the Protean IEF cell (Bio Rad) using
ReadyStrip IPG strips (Bio-Rad, 163-2015) with a pH range of
4–7 according to the manufacturer’s instructions. For the sec-
ond dimension, the IPG strip was resolved on a Criterion 12.5%
Tris-HCl precast gel (Bio-Rad, 345-0102). Two-dimensional
gels were then analyzed by immunoblot as above.
FLAG Immunoprecipitations—For immunoprecipitation of
CaMKK fromHEK 293a cells, 10 g of FLAG-CaMKK were
transiently transfected using 20 l of Lipofectamine 2000 per
100 mm dish according to the manufacturer’s protocol. Cells
were treated with 10 mM roscovitine (Santa Cruz Biotechnol-
ogy, sc-24002) or 100 nM GSK3 inhibitor XV (Calbiochem,
361558) as indicated. Lysates were made from cells 36–48 h
after transfection in Nonidet P-40 lysis buffer. Lysates were
clarified by centrifugation at 18,000  g for 30 min and then
incubated with 10l of anti-FLAGM2-agarose (Sigma, A2220)
for 2 h at 4 °C with constant rocking. Beads were then washed
twice in Nonidet P-40 lysis buffer and once in TBS and eluted
with 1 TBS containing 300 ng/l FLAG peptide (Sigma,
F3290). Immunoprecipitates were then subjected to immuno-
blot analysis.
Pulse-Chase Experiments—FLAG-tagged CaMKK lentivi-
ruswas constructed by inserting two annealed primers contain-
ing the FLAG sequence and NheI overhangs into an NheI cut
pRRLsin.PPT.hPGK.IRES.EGFP-mouse full-length CaMKK
construct that has been described previously (10). CaMKK-
(S129A,S133A,S137A) was made by site-directed mutagenesis
as described above. Primary mouse embryonic fibroblast
(MEFs) were infected with concentrated lentivirus stocks
expressing wild type FLAG-CaMKK or FLAG-CaMKK-
(S129A,S133A,S137A) following previously described proce-
dures (10).MEFswere trypsinized and sorted by flow cytometry
for GFP-positive cells 48 h after infection. Gates were set to
collect populations of MEFs from both infections that had the
same amount of GFP expression. Between 2 and 4  105 cells
were plated in 60-mm culture dishes in DMEM (Mediatech,
10-013-CV) containing 10% FBS, 1 mM HEPES (Invitrogen,
13630), and penicillin/streptomycin solution (Mediatech,
30-002-CI) for 24 h after sort. Before labeling, cells were
switched to DMEM lacking cysteine and methionine (Invitro-
gen, 21013-024) containing 10% FBS, 1 mM HEPES, and peni-
cillin/streptomycin solution for 15min. Cells were then labeled
with 0.44 mCi/ml EasyTag EXPRE35S35S protein labeling mix
(PerkinElmer Life Sciences, NEG772) for 10 min. After the
10-min pulse, cells were chased in regular DMEM supple-
mented with 10% FBS, 5 mM cysteine, 5 mM methionine, 1 mM
HEPES, and penicillin/streptomycin solution. At the indicated
times, cells were lysed in Nonidet P-40 lysis buffer, and FLAG-
CaMKK was immunoprecipitated using anti-FLAG M2-aga-
rose as described above. Immunoprecipitates were fractionated
on an SDS-polyacrylamide gel and silver-stained to visualize
protein. 35S incorporation into CaMKK bands was deter-
mined using a Storm 840 phosphorimager (GE Healthcare),
and the signal was quantified using ImageQuant version 5.2
software (GE Healthcare).
Animals—Camkk2/ mice were generated in our labora-
tory as described previously (18) and backcrossed into a
C57BL/6J background for 10 generations. Control mice were
generated from F1 heterozygous matings and backed-crossed
into the C57BL/6J background for 10 generations. All animals
were bred in the Duke University Medical Sciences Research
Building animal facility under a 12-h light (6:00 a.m. to 6:00
p.m.), 12-h dark (6:00 p.m. to 6:00 a.m.) cycle. Food and water
were provided ad libitum, and all animal care was in compli-
ancewith theNational Institutes ofHealth andDukeUniversity
institutional guidelines governing the use of laboratory and
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experimental animals. CDK5 conditional knock-out brains and
matching controls were a kind gift from the L-H. Tsai labora-
tory and are described elsewhere (23).
Primary Cerebellar Granule Cell (CGC) Isolation—CGCs
were isolated from 6-day-oldmice using a previously published
procedure (10). Cells were cultured in Neurobasal media (NB,
Invitrogen, 21103) supplemented with B27 (Invitrogen, 17504-
044), sodiumpyruvate, L-glutamine, 0.06mg/ml glucose, and 25
mMKCl. CGCswere plated at a density of 2–4 106 cell/well in
6-well dishes that had been coated overnight with 10 g/ml
poly-D-lysine. CGCs were harvested for either protein or RNA
analysis after 24 h in culture.
Cerebellar Granule Cell Transfection and Axon Growth
Measurement—CGCs were plated on 12-mm round poly-D-ly-
sine-coated coverslips placed in 24-well dishes at a density of
250,000 cells per well in NB media supplemented with B27,
sodium pyruvate, L-glutamine, 0.06mg/ml glucose, 25mMKCl,
and 10% Donor Equine Serum. After allowing the cells to rest
for 4 h, medium was removed and replaced with NB medium
with no supplements. Cells were transfected in this medium
with Lipofectamine 2000. For each well, 1 g of total DNA and
1 l of Lipofectamine 2000 were used. After a 45-min incuba-
tion with the DNA-Lipofectamine 2000 complexes, the
medium was replaced with the original culture medium. CGCs
were then cultured for an additional 3 days at 37 °C with 5%
CO2. After 3 days, cells were fixed in 4% formaldehyde in 1
PBS for 15 min at room temperature. Cells were permeabilized
and blocked for 45 min at room temperature in a solution con-
taining 0.2% Triton X-100, 1% Normal Donkey Serum, and 1
PBS. Primary antibodies were diluted as follows in 1 PBS,
anti-GFP (Molecular Probes, A11122) 1:200, and anti-Tau
(Sigma, T9450) 1:500. Coverslips were incubated with primary
antibody overnight at 4 °C in a humidified chamber. The next
day, coverslips were washed with 1 PBS before incubation
with appropriate secondary antibodies, Alexa Fluor 488 anti-
mouse IgG (Molecular Probes), or Cy3 anti-rabbit IgG (Jackson
ImmunoResearch), diluted 1:500 in 1 PBS. After application
of secondary antibody, coverslips were washed with 1 PBS
with the last wash also containing 0.25 g/ml DAPI. Coverslips
weremounted on slides using ProLongGold antifademounting
media (Invitrogen, P36934).
Stained CGCs were visualized on a Zeiss LSM 510 inverted
confocal microscope using a 63 oil immersion objective. GFP
staining was used to indicate transfected neurons, and care was
taken to find GFP-positive neurons that did not overlap
allowing for accurate measurement of neurite length. Length
measurements were made with the line trace function ofMeta-
Morph Premier software version 7.6.5. Neurons were charac-
terized as polarized when the longest neurite was more than
twice as long as the next longest neurite, as has been described
previously (24). In all experiments, there were very few dead
cells as determined by nuclei condensation, and only live cells
were considered for analysis. Transfection efficiency was esti-
mated by counting the number of GFP-positive cells as a per-
centage of total cells. For CGCs transfected with GFP alone,
transfection efficiency was about 10%. All GFP-CaMKK con-
structs used had similar transfection efficiencies around 7%.
RNA Isolation andQuantitative Real Time PCR—Total RNA
was extracted from 2  106 fresh or 1-day in vitro cerebellar
granule neurons using the RNeasy mini kit (Qiagen, 74104),
including the optional on-column DNase digestion (Qiagen,
79254). RNA yield was determined spectrophotometrically.
Single-stranded cDNA was synthesized using SuperScript II
RNase H reverse transcriptase (Invitrogen, 18064-022)
according to the manufacturer’s protocol. Real time PCR was
carried out on a CFX 96 real time system (Bio-Rad) using iQ
SYBR Green Supermix (Bio-Rad, 170-8882) and the following
primers: CaMKK2, 5-CATGAAGGACGCTGC-3 (forward)
and 5-TGACAACGCCATAGGAGCC-3 (reverse); 18 S
ribosomal protein, 5-AGGGTTCGATTCCGGAGAGG-3
(forward) and 5-CAACTTTAATATACGCTATTGG-3
(reverse). Relative levels of CaMKK mRNA were calculated
using the (C(t)) method with 18 S ribosomal protein as a
reference gene.
RESULTS
N-terminal Phosphorylation of CaMKK Results in Altered
CaM Dependence—To evaluate the differences in CaMKK
autonomous activity between enzyme preparations isolated
from bacterial and mammalian sources, we purified CaMKK
from E. coli and the human HEK 293a cell line. We tested
the Ca2/CaM-dependent and -independent activities of
these enzyme preparations using bacterially expressed
AMPK1D139A11 as a substrate. AMPK was chosen as a sub-
strate because it does not require Ca2/CaM binding to be
phosphorylated by CaMKK, as is the case with CaMKI and
CaMKIV (7, 25, 26, 28). Thus, the use of AMPK makes it pos-
sible to measure the Ca2/CaM dependence of CaMKK with-
out concern for the Ca2/CaM dependence of its substrate.
When we tested the activity of our preparations of CaMKK,
we confirmed the observation that bacterially expressed
CaMKK has higher levels of Ca2/CaM autonomous activity
than that prepared frommammalian cells (Fig. 1A). This led us
to hypothesize that CaMKK ismodified inmammalian cells in
a manner that keeps autonomous activity low and increases
Ca2/CaM dependence. As CaMKK has many putative phos-
phorylation sites, we questioned if this modification could be
phosphorylation. To examine this possibility, we isolated
CaMKK from cells that had been labeled with 32P-orthophos-
phate, treated it with -phosphatase, and found that phospha-
tase treatment decreased the total phosphate incorporation by
80% (supplemental Fig. 1). This result reveals that CaMKK is
phosphorylated in vivo and that we can successfully remove
the majority of this phosphorylation with -phosphatase
treatment. Next, the Ca2/CaM-dependent and -indepen-
dent activities of phosphatase-treated HEK 293a-produced
CaMKK were assayed using the same bacterially expressed
AMPK1D139A11 as a substrate. As shown in Fig. 1B, the
phosphatase-treated CaMKK had increased Ca2/CaM-in-
dependent activity compared with untreated CaMKK.
Using TOF mass spectrometry analysis of FLAG-CaMKK
produced in the mammalian COS-7 cell line, we observedmul-
tiple peaks corresponding to multiple phosphorylated forms of
CaMKK (Fig. 1C). Phosphopeptide sequencing was then used
to identify seven phosphorylation sites on CaMKK (Fig. 1D
CaMKK Is Regulated by Multisite Phosphorylation
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and supplemental Fig. 2, and data not shown). To determine
which of these sites contribute to theCa2/CaMdependence of
CaMKK, a series of serine to alaninemutantswas constructed.
Ser-100, Ser-495, and Ser-511 are homologous to PKA sites in
CaMKK (29, 30), and phosphorylation ofCaMKKbyPKAon
Ser-100 and Ser-511 leads to the recruitment of 14-3-3 and
inactivation of the enzyme (19, 20). Interestingly, although we
were able to confirm the observation that CaMKK associates
with 14-3-3 after stimulation of PKA activity, CaMKK was
unable to recruit 14-3-3 under the same conditions (supple-
mental Fig. 3). Furthermore, a CaMKK S100A,S495A,S511A
triplemutant had activity similar to the wild type protein in our
in vitro kinase assays (data not shown). From these data, we
conclude that the phosphorylated residues that alter CaMKK
autonomous activity are not homologous to the PKA sites in
CaMKK.
FIGURE 1. CaMKK activity is modified by phosphorylation. A, in vitro kinase assay measuring the ability of mammalian 293a CaMKK or E. coli CaMKK to
phosphorylate AMPK. CaMKK preparations were incubated with bacterially produced AMPK1D139A11 in the presence of [-
32P]ATP and Ca2/CaM or EGTA
for the indicated amounts of time. Reactions were then subjected to SDS-PAGE and staining with Coomassie Blue. Bands corresponding to the AMPK subunit
were excised, and the amount of 32P incorporated was measured by scintillation counting. Activities are presented as a percent of the maximal activity
(CaM-dependent activity at 45 min) to correct for variation in protein yields. Data shown are the average of at least three independent experiments. Error bars
represent standard error. B, in vitro kinase assay comparing the activity of wild type and -phosphatase-treated CaMKK purified from mammalian cells. Assays
were performed as in A. Data shown are the average of at least three independent experiments. Error bars represent standard error. C, TOF-MS analysis of wild
type (WT) CaMKK. The major peak corresponds to a triple-phosphorylated form of CaMKK. Shift of the dominant peak in TOF-MS analysis of CaMKK S129A,
S133A, and S137A single mutants implies sequential phosphorylation. D, schematic of CaMKK domain structure showing phosphorylated residues identified
by mass spectrometry. Autoreg/CaM, autoregulatory domain and calmodulin binding domains that overlap in CaMKK. E, alignment of region surrounding
N-terminal phosphorylation sites Ser-129, Ser-133, and Ser-137. Phosphorylation sites with neighboring prolines are highlighted in boldface type. Motif is
conserved in mouse, rat, and human CaMKK but not in CaMKK.
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Previous studies involving truncation mutants of CaMKK
suggest that a region of the N terminus spanning residues
129–151 is responsible for generating autonomous activity
of the enzyme (21). Our mass spectrometry phosphopeptide
sequencing data revealed three CaMKK phosphorylation
sites, Ser-129, Ser-133, and Ser-137, which fall within this
region (supplemental Fig. 2). These sites are conserved in
mouse, rat, and human isoforms of CaMKK, but the region
shares little homology with CaMKK (Fig. 1E). Thus,
we made a CaMKK S129A,S133A,S137A triple mutant
(CaMKK(S129A,S133A,S137A)) and compared its activity
with the wild type protein. We found that this phospho-defi-
cient mutant did indeed exhibit increased autonomous activity
with no change in Ca2/CaM-dependent activity (Fig. 2A). In
addition, activity of CaMKK(S129A,S133A,S137A) was unal-
tered by -phosphatase treatment indicating that these are the
primary residues responsible for altering Ca2/CaM autono-
mous activity (data not shown).
To further validate importance of Ser-129, Ser-133, and Ser-
137 in generation of CaMKK autonomous activity, we
mutated them to aspartic acid in a bacterially produced version
ofCaMKK (CaMKK(S129D,S133D,S137D)) in an attempt to
mimic the phosphorylated state. Comparison of the activity of
this phospho-mimetic to the wild type protein revealed that
CaMKK(S129D,S133D,S137D) had decreased autonomous
activity (Fig. 2B). Thus, the bacterially produced CaMKK-
(S129D,S133D,S137D) mimics the phosphorylated form of the
wild type protein purified from mammalian cells. Taken
together, these data indicate that phosphorylation of CaMKK
at Ser-129, Ser-133, and Ser-137 in the N terminus of the pro-
FIGURE 2. Phosphorylation of CaMKK on Ser-129, Ser-133, and Ser-137 in the N terminus is responsible for decreased autonomous activity. A, in vitro
kinase assay measuring the ability of wild type CaMKK and CaMKK(S129A,S133A,S137A) produced in mammalian cells to phosphorylate AMPK. Assays were
performed as in Fig. 1A. Data shown are the average of at least three independent experiments. Error bars represent standard error. B, in vitro kinase assay
measuring the activity of bacterially expressed wild type CaMKK or CaMKK(S129D,S133D,S137D). Assays were performed as in Fig. 1A. Data shown are the
average of at least three independent experiments. Error bars represent standard error. C, FLAG-tagged wild type CaMKK or CaMKK(S129A,S133A,S137A)
were partially purified from HEK 293a cells and immunoblotted with a commercially available phosphoserine (pSerine) antibody. The membrane was also
blotted for FLAG as a loading control. D, FLAG-tagged wild type CaMKK or CaMKK S129A, S133A, or S137A single point mutants were partially purified from
HEK 293a cells and immunoblotted with a commercially available phosphoserine antibody. The membrane was also blotted for FLAG as a loading control.
E, two-dimensional gel analysis of wild type CaMKK and CaMKK(S129A,S133A,S137A) purified from mammalian cells. Top and middle panels show wild type
CaMKK blotted with FLAG and phosphoserine antibodies, respectively. Bottom panel shows CaMKK(S129A,S133A,S137A) blotted with FLAG antibody.
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tein leads to decreased Ca2/CaM autonomous activity and
that phosphorylation of these sites can bemimicked in the bac-
terially expressed formof the enzymebymutating the serines to
aspartic acids.
The dominant peak from our TOFmass spectrometry corre-
sponds to a triple phosphorylated form of CaMKK. We then
questioned if this peak corresponded to CaMKK phosphory-
lated on Ser-129, Ser-133, and Ser-137. To test this, we per-
formedTOFmass spectrometry on the corresponding serine to
alanine mutants of CaMKK expressed in COS-7 cells. The
S137Amutant resulted in the dominant CaMKK peak having
no phosphates, whereas the S133A mutant major peak had a
single phosphate and the S129A mutant had two phosphates
(Fig. 1C). These data indicate that Ser-129, Ser-133, and Ser-
137 contribute to the dominant phosphorylated form of
CaMKK. In addition, these data indicate that phosphorylation
of Ser-129, Ser-133, and Ser-137 are coordinately regulated
with priming of Ser-137 being required before subsequent
phosphorylation of Ser-133 and then Ser-129. To further vali-
date our TOF mass spectrometry data, we performed a two-
dimensional gel analysis on wild type CaMKK and
CaMKK(S129A,S133A,S137A). To detect phosphorylated
protein, we used a commercially available phosphoserine anti-
body, which we found recognized wild type CaMKK but not
CaMKK(S129A,S133A,S137A) (Fig. 2C). To determine which
sites the phosphoserine antibody recognized, we tested its reac-
tivity with CaMKK S129A, S133A, and S137A single point
mutants. As seen in Fig. 2D, mutating any one of these three
sites individually leads to loss of reactivity with the phosphoser-
ine antibody. Because our TOF mass spectrometry data with
the CaMKK single mutants indicate mutation of Ser-133
blocks phosphorylation of Ser-129 and mutation of Ser-137
blocks phosphorylation of Ser-133 and Ser-129, we suggest that
the phosphoserine antibody is most likely recognizing Ser-129.
In the two-dimensional gel, wild type CaMKK resolved into a
series of four spots, which all reacted with the phosphoserine
antibody (Fig. 2E). CaMKK(S129A,S133A,S137A) resolved
into a single spot that was right-shifted when compared with
the wild type protein and failed to show any reactivity with the
phosphoserine antibody (Fig. 2E and data not shown). From
this experiment, we conclude that in cells CaMKK is phos-
phorylated constitutively on Ser-129, Ser-133, and Ser-137.
N Terminus of CaMKK Is Sequentially Phosphorylated by
CDK5 and GSK3—Because CaMKK is phosphorylated in
mammalian cells, wewanted to determine the protein kinase or
kinases responsible. FromourTOFmass spectrometry data, we
suspected that phosphorylation of Ser-129, Ser-133, and Ser-
137 is coordinately regulated. Supporting this idea, the spacing
of the residues resembles a consensus glycogen synthase kinase
3 (GSK3) phosphorylationmotif, and it is common for GSK3 to
require a priming phosphorylation event (31). If this were the
case for CaMKK, the prediction would be that Ser-137 was
phosphorylated first, followed by GSK3-dependent phosphor-
ylation of Ser-133 and Ser-129. To help direct the search for the
putative CaMKK priming kinase, we used the Scansite pro-
gram to search kinases that might recognize the region around
the Ser-137 site and identified cyclin-dependent kinase 5
(CDK5) (32). To test this idea, we incubated purified active
CDK5with bacterially produced and catalytically inactiveGST-
CaMKK D311A in the presence of [-32P]ATP and found
CaMKK to be phosphorylated with 32P (Fig. 3A). Because
there was a greatly diminished phosphorylation of a GST-
CaMKK D311A,S137A mutant, it is likely that Ser-137 is the
primary site of phosphorylation by CDK5 (Fig. 3A). We then
examined the phosphorylation of CaMKK by GSK3. For
these experiments, we incubated phosphatase-treated HEK
293a-purifiedCaMKK in the presence or absence of CDK5 for
an hour before addition of purified, active GSK3. We used the
phosphoserine antibody to detect phosphorylation of
CaMKK. We found that incubation with either CDK5 or
GSK3 alone was insufficient to produce reactivity with the
phosphoserine antibody. However, incubation with CDK5 fol-
lowed by GSK3 produced a robust phosphoserine signal.
These data demonstrate that CDK5 and GSK3 can phosphor-
ylate CaMKK in vitro and that the phosphorylation events
catalyzed by these protein kinases are sequential, with phos-
phorylation of Ser-137 by CDK5 being required for the subse-
quent phosphorylation of CaMKK by GSK3 on Ser-133 and
Ser-129.
We next questioned if CaMKK could be phosphorylated by
CDK5 and GSK3 in our HEK 293a cell system. To test if
CaMKK is phosphorylated byGSK3,we inhibitedGSK3 activ-
ity using the GSK3 inhibitor XV compound (33). After an over-
night treatment of the cells with 0.1 M of the GSK3 inhibitor,
all reactivitywith the phosphoserine antibodywas lost (Fig. 3C).
This indicates that CaMKK fails to be phosphorylated in the
absence of GSK3 activity. We also treated HEK 293a cells with
10 M roscovitine, an inhibitor of CDC2, CDK2, and CDK5.
FIGURE 3. CDK5 and GSK3 phosphorylate CaMKK in vivo. A, in vitro kinase
assay in which 5 g of bacterially purified GST-CaMKK D311A or GST-
CaMKK D311A, S137A was incubated with 0.234 g of active p35/CDK5 in
the presence of [-32P]ATP for the indicated times. Top panel is autoradio-
graph, and bottom panel is Coomassie-stained gel to show loading. CBB, Coo-
massie Blue. B, in vitro kinase assay in which 0.5 g of HEK 293a-expressed
FLAG-CaMKK was incubated with active GSK3 either with (right) or without
(left) preincubation with CDK5/p35. C, FLAG-CaMKK was transiently overex-
pressed in HEK 293a cells. The cells were then treated overnight with 0.1 M
GSK3 inhibitor XV before being lysed. CaMKK was immunoprecipitated from
the lysate and immunoblotted using the phosphoserine (pSerine) antibody
described in Fig. 2C and FLAG antibody as a loading control.
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Treatment of cells with roscovitine was limited to 1 h as previ-
ous reports have demonstrated that CDK5/p35 is turned over
rapidly, and newly synthesized kinase will be free of inhibitor
(34). Following this short treatment, we were unable to detect
any change in phosphoserine levels on CaMKK (data not
shown). This is most likely due to the short duration of treat-
ment, and it does not exclude CDK5 as the kinase responsible
for CaMKK phosphorylation.
CDK5-dependent Phosphorylation Regulates the Turnover of
CaMKK—While working with the CaMKK mutants, we
noted that expression of CaMKK(S129D,S133D,S137D) was
higher than wild type CaMKK (data not shown). This sug-
gested to us that phosphorylation ofCaMKKmay influence its
turnover. To test this theory, we used a pulse-chase experiment
to measure the rate of turnover of wild type CaMKK and
CaMKK(S129A,S133A,S137A). MEFs, a readily available pri-
mary cell line, were infected with lentiviruses expressing either
wild type CaMKK or CaMKK(S129A,S133A,S137A). The
MEFs were then pulsed with media containing 35S-labeled
methionine and -cysteine. After a 10-min pulse, the cells were
chased in label-free media for the indicated times. We found
that wild type CaMKK decays linearly with a half-life of
30.7 h (Fig. 4A). Interestingly, decay of CaMKK-
(S129A,S133A,S137A) is bi-phasic. During the first phase, the
mutant protein is rapidly degraded with a half-life of 2.1 h.
However, by the 6-h chase time point, 60% of the labeled
protein remains, and the decay curve levels off giving a half-life
of 51.2 h. As a control, we measured the rate of 35S turnover in
crude lysates, and we found no difference between those
derived from the CaMKK(S129A,S133A,S137A) or wild type
lysates (Fig. 4B). These data indicate that phosphorylation of
newly synthesizedCaMKK is critical for its stability, as protein
that cannot be phosphorylated is rapidly degraded. Thus, one
function of phosphorylation of CaMKK is to regulate stability
of newly synthesized protein. Because CDK5 phosphorylation
is required prior to GSK3, we believe that regulation of CDK5
activity is probably most influential in determining CaMKK
phosphorylation status. Thus, we predicted that the absence of
CDK5 activity would lead to decreased levels of CaMKK
protein.
CDK5/p35 Activity Regulates the Level of CaMKK in Pri-
mary Brain Tissues and Cultured Neurons—To examine the
consequence of loss of CDK5 activity on CaMKK, we exam-
ined CaMKK levels in a CDK5 knock-out mouse model. The
CDK5 global knock-out mouse displays embryonic and perina-
tal mortality (35), so we used CDK5 conditional knock-outs
that lack CDK5 in CaMKII-positive neurons (23). We exam-
ined CaMKK in cortex and hippocampus from these animals,
as these are regions of the brain where both CaMKK and
CDK5 are expressed (2, 36). In accordance with our prediction
that CDK5 phosphorylation regulates CaMKK levels, we
found a 43% reduction of CaMKK in cortex and a 45% reduc-
tion in hippocampus in the CDK5 conditional knock-outs (Fig.
5, A and B). Levels of the CaMKK substrate CaMKI were
unchanged, indicating specificity forCaMKK (Fig. 5,A andB).
From this, we concluded that absence of CDK5 activity leads to
a reduction in CaMKK, and this effect is specific as CaMKI
levels are not altered.
Interestingly, levels of CDK5 activity are developmentally
regulated in the central nervous system and correlate with the
cessation of neuronal proliferation and the start of migration
and neurite outgrowth (36). Much like the cyclin-dependent
kinases, CDK5 activity is dependent on expression and binding
of a small protein activator (37). Two CDK5 activators, p35 and
p39, have been identified with p35 being the better studied of
the two. A good in vitromodel of neuronal differentiation is the
culture of cerebellar granule cells (CGCs). Cerebellar granule
precursors can be isolated from neonatal mouse cerebellum
and differentiate in culture. Previous work from our laboratory
has shown that lack of CaMKK impairs the ability of CGCs to
cease proliferation in the external granule cell layer, and
FIGURE 4. Phosphorylation of CaMKK regulates its turnover. A, pulse-
chase experiment examining the half-life of CaMKK in MEFs. MEFS were
infected with a lentivirus containing either wild type FLAG-CaMKK or FLAG-
CaMKK(S129A,S133A,S137A). Cells were pulsed with 35S-labeled Cys/Met
mixture and after that pulse cells were chased in normal medium supple-
mented with 5 mM methionine and cysteine. Cells were harvested at the indi-
cated times, and CaMKK was immunoprecipitated with a-FLAG M2-agarose.
The immunoprecipitates were subjected to SDS-PAGE and silver-stained, and
35S incorporated into CaMKK was quantified using a PhosphoImager. These
values were expressed as a percent of signal at time 0. Data are average of four
experiments. Error bars represent standard error. B, to ensure that 35S labeling
was properly quenched during the pulse-chase experiments in A, 5–10 g of
total protein from each time point was precipitated with TCA, and total
counts present were quantified by scintillation counting. As expected,
amount of 35S radioactivity decreases rapidly throughout the experiment.
Data are average of four experiments. Error bars represent standard error.
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migrate into the internal granule cell layer of the cerebellum
(10). Thus, we decided to examine the relationship between
CDK5 and CaMKK in cultured primary CGCs.We compared
the protein levels of CDK5, p35, and CaMKK in lysates from
freshly isolated, mitotically active CGC precursors and CGCs
that had been cultured for 1 day in vitro allowing them to dif-
ferentiate. Although levels of CDK5 were unchanged, we
observed a large increase in p35 levels in differentiated cells,
which correlated with an increase in total CaMKK (Fig. 6, A
andB). This increase inCaMKKwas not due to a change in the
level of CaMKK transcription, as levels of mRNA remained
constant (Fig. 6C). Thus, levels of CaMKK increase during
neuronal development, and this increase correlates with
increased CDK5 activity.
Phosphorylation of CaMKK by CDK5 Is Important in Neu-
rite Outgrowth—We next questioned why induction of
CaMKK is important during development of CGC. To
address this question, we first examined the subcellular local-
ization of CaMKK in developing CGCs after transfection of
CaMKK null CGCs with GFP fusions of wild type CaMKK,
CaMKK(S129A,S133A,S137A), or CaMKK(S129D,S133D,-
S137D). CaMKK was visualized by staining for GFP in fixed
neurons, and axons were visualized with Tau-1 staining. We
found that all three CaMKK constructs shared a similar dis-
tribution patternwith signal in the cell body and along the axon.
In addition, we found CaMKK to be enriched in growth cones
(indicated with arrows, Fig. 7, A–C). Thus, CaMKK is widely
distributed in neurons, and localization is not grossly disrupted
by changing phosphorylation status.
The growth cone is a specialized structure that controls out-
growth of neurites by responding to extracellular cues, some of
which trigger Ca2 signaling (38). Because CaMKK localizes
to growth cones, we hypothesized that it may play a role in
neurite outgrowth. In cerebellar granule neurons, as in most
other neurons, neurite outgrowth is polar leading to a typical
morphology characterized by a single long axon and several
shorter dendrites. To examine the role of CaMKK in neurite
outgrowth, we examined the morphology of CGCs isolated
from wild type and CaMKK null mice transfected with GFP.
After 3 days in vitro, neurons isolated from both wild type and
CaMKK null mice displayed a consistent polar morphology,
including a single long process (axon) andmultiple shorter pro-
cesses (dendrites) (Fig. 8,A, B, andG). However, when wemea-
sured the length of the longest primary neurite, we found a
FIGURE 5. CDK5 activity correlates with CaMKK levels in mouse brain tissues. A, lysates made from control or CDK5 conditional knock-out (CDK5 cKO)
cortex (Ctx) or hippocampus (Hipp) were blotted with antibodies to pan-CaMKK, CaMKI, -actin, and CDK5. To help in the identification of CaMKK versus
CaMKK, brain extracts from wild type and CaMKK knock-out mice were run in the left two lanes. B, quantification of A. Error bars represent standard error, and
p values were calculated using an unpaired Student’s t test.
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significant decrease in the CaMKK null CGCs (Fig. 8F). This
indicated a defect in neurite extension and is consistent with
previous reports (11, 13). We then questioned what effect wild
type CaMKK, CaMKK(S129A,S133A,S137A), or CaMKK-
(S129D,S133D,S137D) would have on CGC morphology and
neurite outgrowth. Thus, we transfected CaMKK null CGCs
with GFP fusions of these constructs and analyzed them as we
did the wild type and CaMKK null CGCs. We found that the
neurons expressing both the wild type and CaMKK-
(S129A,S133A,S137A) constructs had normal polar morphology
(Fig. 8, C, D, and G). However, the neurons transfected with
CaMKK(S129D,S133D,S137D) displayed a striking phenotype
whereby they failed to establish appropriate axon-dendrite polar-
ity and instead grew several long neurites (Fig. 8, E and G). This
defect is similar to that seen in rat hippocampal neurons overex-
pressing activeCaMKI (12) and indicates adefect in establishment
of appropriate polarity during neurite outgrowth. We next mea-
sured the length of the longest neurite in the CaMKK null CGC
expressing wild type CaMKK, CaMKK(S129A,S133A,S137A),
and CaMKK(S129D,S133D,S137D) constructs. We found that
both wild type CaMKK and CaMKK(S129A,S133A,S137A)
were able to restore the decrease in primary neurite length
observed in the CaMKK null neurons (Fig. 8F). However,
CaMKK(S129D,S133D,S137D) was unable to rescue the defect
in primary neurite length (Fig. 8F). This is consistent with the
observation that these neurons are nonpolar and fail to grow a
single long process (Fig. 8, E and G). Together, these data indi-
cate that appropriate regulation of CaMKK by phosphoryla-
tion is critical for neurite outgrowth during neuronal
development.
DISCUSSION
In this study, we report the novel regulation of CaMKK
activity by multisite phosphorylation. We find that CaMKK
autonomous activity is decreased following phosphorylation on
three sites in the N terminus (Ser-129, Ser-133, and Ser-137),
and we identify CDK5 and GSK3 as the kinases responsible for
these phosphorylation events and show they act sequentially
with CDK5 priming for subsequent phosphorylation by GSK3.
In addition, we find that CaMKK isolated from mammalian
cells is constitutively phosphorylated, leading us to believe that
this is a mechanism by which cells keep CaMKK autonomous
activity low allowing for tight control of activity by Ca2/CaM.
In addition to regulation of autonomous activity, we find that
phosphorylation of CaMKK by CDK5 and GSK3 regulates its
half-life. From the results of pulse-chase experiments, we con-
clude that phosphorylation of Ser-129, Ser-133, and Ser-137 is
critical for stability of newly synthesized protein. Because
CaMKK needs to be phosphorylated by CDK5 before it can be
phosphorylated by GSK3, we predicted that regulation of
CDK5 activity would correlate with CaMKK phosphorylation
and stability. Our data fromCDK5 conditional knock-out mice
support this as the cortex and hippocampus from these animals
have a significant decrease in CaMKK protein. In addition to
CaMKK, the CDK5 substrate tyrosine hydroxylase is regu-
lated in a similar fashion as phosphorylation also regulates its
FIGURE 6. CDK5 activity correlates with CaMKK levels in primary CGC cultures. A, 75 g of lysate from freshly isolated WT or 1 day in vitro (1DIV) WT CGCs
were immunoblotted with pan-CaMKK, p35, CDK5, and -actin antibodies. Representative blot is from four independent experiments. B, quantification of A.
Combined analysis is from four independent experiments. Error bars represent standard error, and p values were calculated using an unpaired Student’s t test.
C, real time PCR analysis of CaMKK mRNA from freshly isolated WT or 1 day in vitro (1DIV) WT CGCs. Combined analysis is from three independent experiments.
Error bars represent standard error, and changes in CaMKK mRNA were determined to be nonsignificant (NS) based on a p value 0.05 as calculated by an
unpaired Student’s t test.
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stability (39). Thus, one important effect of CaMKK phos-
phorylation is to stabilize and thereby increase cellular levels of
CaMKK.
CDK5 activity is developmentally regulated and correlates
with a switch from a proliferative state to a migratory state in
neurons (36). Although CDK5 is ubiquitously expressed, its
activity is regulated by co-expression of two small protein acti-
vators p35 and p39 (37, 40, 41). Studies in CDK5, p35, and p39
knock-out models demonstrate the importance of CDK5 activ-
ity in neuronal development, especially in the cortex (35, 42). In
addition,CDK5 activity is important in themigration of granule
cells in the developing cerebellum (43). Previous data from our
laboratory demonstrated that the absence of CaMKK causes a
defect in the developing cerebellum whereby granule cells fail
to cease proliferation and migrate properly (10). This led us to
believe that induction of CDK5 activity during development
would increase CaMKK levels allowing for its proper function
in developing neurons. Our data from cultured CGCs support
this theory. In CGCs, we reveal that CaMKK levels increase in
concert with p35 levels as the cells differentiate in culture.
Thus, CaMKK levels are regulated during development.
We then questioned the role up-regulation of CaMKK may
play during CGC development. When we examined CaMKK
localization in CGC, we noticed it was enriched in growth
cones. Enrichment of CDK5 and its activator p35 has also been
reported in growth cones, and work in cultured cortical neu-
rons demonstrated a requirement for CDK5 during neurite
outgrowth (44). Previous work has demonstrated that a
CaMKK/CaMKI pathway contributes to axon outgrowth
through the regulation of growth cone motility (11). This led us
tobelieve thatphosporylationofCaMKKbyCDK5 in thegrowth
cone could be important in neurite outgrowth, so we examined
neurite outgrowth in our CGC model. We found that CaMKK
null CGCs grow shorter primary neurites than wild types, and we
were able to rescue this defect with wild type CaMKK and
CaMKK(S129A,S133A,S137A). This indicates that phosphory-
lation of CaMKK is not critical for its role in neurite extension.
Surprisingly, CaMKK(S129D,S133D,S137D) was unable to
recover the defect in primary neurite outgrowth and caused an
additional defect in the establishment of appropriate neuronal
polarity.This indicatesCaMKKhasanadditional role in theearly
stages of neurite outgrowth during which appropriate axon-den-
drite polarity is established fromthepolarized emergenceof axons
and dendrites (45). This is consistent with previous work show-
ing that constitutive activation of CaMKK/CaMKI pathways
during the early stages of hippocampal neuron differentiation
leads to the development of multiple axons (12). Thus, we con-
clude from our data that appropriate phosphorylation of
CaMKK is most critical during the early stages of neurite out-
growth in which neuronal polarity is established.
During the establishment of neuronal polarity, signaling
molecules acquire a polarized distribution because of processes
such as local protein translation and degradation in the emerg-
ing processes (45). One intriguing explanation for the pheno-
FIGURE 7. Localization of CaMKK in developing CGCs. A–C, CaMKK null CGCs were transfected with GFP-tagged wild type CaMKK (A),
CaMKK(S129A,S133A,S137A) (B), or CaMKK(S129D,S133D,S137D) (C) constructs as indicated on the left. Cells were then stained for GFP (red) to visualize
CaMKK and Tau-1 (green) to visualize axons. Panel on right shows overlay of signals along with DAPI (blue) to stain nucleus. Arrows point to growth cones. Scale
bar, 20 M. Representative images are from four independent experiments.
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type generated by CaMKK(S129D,S133D,S137D) is that
CaMKK is locally synthesized and phosphorylated in the neu-
rite that will become the axon leading to its enhanced stability.
Local synthesis of polarity proteins such as Par-3 is known to
occur in axons and be essential for axon specification and
growth (46). In addition, the CaMKK downstream target
cAMP-response element-binding protein is also known to be
locally translated in axons where it is postulated to be more
susceptible to modification before being transported to the
nucleus where it influences transcription of target genes (47). If
CaMKK was also locally modified by CDK5, in the case of
CaMKK(S129D,S133D,S137D) this localized regulation
would be lost and could lead to the inappropriate initiation
and growth of the multiple nonpolarized neurites seen in our
experiments. Additional work will be required to confirm
this theory.
There are several possibleCaMKKdownstream targets that
couldmediate its role in neurite outgrowth. In cortical neurons,
CaMKK-CaMKI and CaMKK-CaMKI pathways have been
implicated in the growth of axons and dendrites, respectively
(13, 48). In addition, regulation of CaMKI by CaMKK has also
been implicated in the early stages of axon formation (12). In
cortical and hippocampal neurons, both CaMKK and
CaMKK are expressed, and it is not clear in these model sys-
tems which isoform is most important for CaMKI activation.
Because CGCs express higher levels of CaMKK than
CaMKK (49), it is reasonable to assume CaMKK may be the
more important kinase isoform in this type of neuron.
In addition to regulating CaMKI, CaMKK also regulates
CaMKIV. Our previous work on the cerebellum of CaMKIV
and CaMKK null animals implicates a CaMKK/CaMKIV/
cAMP-response element-binding protein signaling pathway in
FIGURE 8. Phosphorylation of CaMKK is important in neurite outgrowth. A–E, representative images showing morphology of wild type neurons
transfected with GFP (A), CaMKK null neurons transfected with GFP (B), or CaMKK null neurons rescued with wild type CaMKK-GFP (C),
CaMKK(S129A,S133A,S137A)-GFP (D), or CaMKK(S129D,S133D,S137D)-GFP (E). Neurons were stained with GFP (red) to visualize CaMKK and Tau (green) to
visualize axons. Panel on right shows overlay of signals along with DAPI (blue) to stain nucleus. Arrows point to primary neurite (axon) that continues out of view,
and arrowheads indicate shorter secondary neurites (dendrites). Scale bar, 20 m. F, length of axons as measured in WT or CaMKK null (KO) CGCs transfected
with the indicated GFP fusion constructs after 3 days in vitro. At least 40 neurons were measured for each condition from three independent experiments. Error
bars represent standard error, and p values were calculated using an unpaired Student’s t test. G, polarity of neurons was determined for WT and CaMKK null
(KO) CGCs transfected with the indicated GFP fusion constructs after 3 days in vitro. At least 40 neurons were measured for each condition from three
independent experiments. Error bars represent standard error.
CaMKK Is Regulated by Multisite Phosphorylation
AUGUST 12, 2011 • VOLUME 286 • NUMBER 32 JOURNAL OF BIOLOGICAL CHEMISTRY 28077










the regulation of brain-derived neurotrophic factor (BDNF)
transcription. BDNF is an important neurotrophin in CGC
development influencing survival, migration, neurite out-
growth, and synapse development (50–52). Recent work also
demonstrates that the BDNF receptor TrkB adopts a polarized
distribution in CGCswith the highest levels present in the lead-
ing process (53). This polarization is critical for migration of
CGCs along BDNF gradients in the developing cerebellum.
BecauseCaMKK regulates BDNF levels, disruption of this sig-
naling pathway may adversely influence the establishment of
BDNF gradients critical for appropriate CGC polarization and
migration.
Recent work has also implicated the CaMKK target AMPK
in neuronal polarization and neurite growth (27). In these stud-
ies, hippocampal neuronswere treatedwith theAMPKagonists
metformin or 5-aminoimidazole-4-carboxamide-1--riboside,
and Amato et al. (27) noticed a failure to establish appropriate
polarity as well as a decrease in total neurite length. This
is similar to what we observe when we overexpress
CaMKK(S129D,S133D,S137D). Further work is required to
determine whether the phenotype we observe is due to
increased activation of AMPK.
Thus, we have described herein a novel CDK5/GSK3-depen-
dent mechanism responsible for the regulation of CaMKK
activity. In the future, it will be necessary to consider the phos-
phorylation status of CaMKK in addition to Ca2/CaM bind-
ing to better understand regulation of CaMKK-dependent
signaling pathways.
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Supplemental Figure 1  
(A) FLAG-CaMKK was transiently over-expressed in HEK 293a cells and labeled for 4 h with 0.77 
mCi/ml of 
32
P-orthophosphate. CaMKK was then partially purified using anti-FLAG M2-agarose. The 
sample was split and half was treated with -phosphtase for 1 h while the other half was left untreated. 
After phosphatase treatment, CaMKK attached to anti-FLAG M2-agarose was washed extensively 
before CaMKK was eluted using the FLAG peptide. Samples were run on a SDS-PAGE gel, silver 
stained, and then visualized on autoradiograph film.  
(B) Bands containing CaMKK were cut from the gel in (A) and levels of 
32
P incorporation were 
measured using scintillation counting.  
Supplemental Figure 2 
Phosphopeptide sequence of human CaMKKβ (121-142). Human FLAG-CaMKKβ was isolated by 
immunoprecipitation, digested with trypsin and subjected to targeted MS/MS as described in 
Experimental Procedures.  The parent triply charged ion is marked * (909.05); annotated a, b and y ions 
of the MS/MS spectrum are shown, the specific ions identifying pSer137, pSer133 and pSer129 are 
highlighted on the sequence. 
Supplemental Figure 3 
 FLAG-CaMKK and FLAG-CaMKK were transiently over-expressed in HEK 293a cells. The cells 
were then treated as indicated with 100mM dibutryl-cAMP for 10 min before being harvested in lysis 
buffer. FLAG-CaMKK constructs were immunoprecipitated with anti-FLAG M2 agarose and the 
immunoprecipitates were blotted with a pan 14-3-3 antibody as well as a FLAG antibody as a loading 
control.  
Supplemental Table 1 
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